Wire
AC Immune to Obtain $4 Million Research Grant From Foundation for Parkinson's Disease Therapy Trial
AC Immune (ACIU) is set to obtain a research grant of $4 million from the Vijay and Marie Goradia Charitable Foundation to support its phase 2 trial evaluating ACI-7104 in early Parkinson's disease, the company said Thursday.The grant will support extending the first part of the trial, and will help assess the long-term safety and efficacy of the active immunotherapy for an additional two years, according to a statement.AC Immune said that the final results of the trial's first part is expected in H2.Price: $2.16, Change: $+0.04, Percent Change: +1.89%
$ACIU
